Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.58B | 20.87B | 21.49B | 20.69B | 19.74B | 19.71B |
Gross Profit | 5.80B | 5.70B | 6.01B | 5.04B | 4.65B | 4.78B |
EBITDA | 1.68B | 1.75B | 1.81B | 1.26B | 1.12B | 1.16B |
Net Income | 873.96M | 792.00M | 959.63M | 559.00M | 412.78M | 420.88M |
Balance Sheet | ||||||
Total Assets | 20.23B | 18.72B | 20.33B | 18.67B | 17.74B | 16.81B |
Cash, Cash Equivalents and Short-Term Investments | 4.96B | 3.80B | 4.70B | 3.48B | 2.95B | 2.24B |
Total Debt | 4.63B | 4.63B | 4.52B | 4.14B | 4.28B | 4.48B |
Total Liabilities | 10.92B | 9.22B | 11.35B | 10.73B | 10.22B | 9.63B |
Stockholders Equity | 9.30B | 9.49B | 8.98B | 7.93B | 7.52B | 7.18B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -280.00M | 1.40B | 1.09B | 1.24B | 399.27M |
Operating Cash Flow | 0.00 | -223.00M | 1.54B | 1.12B | 1.28B | 530.27M |
Investing Cash Flow | 0.00 | -66.00M | -146.03M | -141.11M | -42.94M | -123.94M |
Financing Cash Flow | 0.00 | -609.00M | -173.50M | -448.95M | -530.28M | -448.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | €160.61B | 12.93 | 12.17% | 2.68% | 3.32% | 21.22% | |
71 Outperform | ¥254.47B | 13.17 | 8.49% | 3.06% | 6.31% | 13.07% | |
69 Neutral | ¥5.19B | 6.54 | 4.64% | -2.87% | -17.39% | ||
68 Neutral | $997.82B | 17.71 | 18.79% | 2.49% | 8.39% | 34.99% | |
64 Neutral | ¥8.65B | 3.91 | 3.63% | 3.45% | 29.89% | ||
62 Neutral | $496.27B | 247.85 | 0.35% | 5.21% | 1.45% | ― | |
54 Neutral | ¥20.23B | ― | 3.88% | -0.87% | -288.95% |